Share on StockTwits

GTx (NASDAQ:GTXI) Insider Jason T. Shackelford purchased 10,000 shares of GTx stock in a transaction dated Thursday, August 7th. The stock was purchased at an average cost of $0.92 per share, with a total value of $9,200.00. Following the completion of the acquisition, the insider now directly owns 45,263 shares of the company’s stock, valued at approximately $41,642. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.

Shares of GTx (NASDAQ:GTXI) opened at 1.00 on Friday. GTx has a one year low of $0.81 and a one year high of $4.65. The stock’s 50-day moving average is $1.28 and its 200-day moving average is $1.50. The company’s market cap is $75.2 million.

GTx (NASDAQ:GTXI) last issued its quarterly earnings data on Tuesday, August 5th. The company reported ($0.15) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.12) by $0.03. During the same quarter in the previous year, the company posted ($0.20) earnings per share. On average, analysts predict that GTx will post $-0.47 earnings per share for the current fiscal year.

GTx, Inc is a biopharmaceutical company. The Company is developing selective androgen receptor modulators (NASDAQ:GTXI) , a drugs with the potential to prevents and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia (age related muscle loss).

Receive News & Ratings for GTx Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GTx Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.